Medifacts International
2101 Gaither Road
Suite 400
Rockville
Maryland
20850
United States
Tel: 301-795-2508
Fax: 240-597-5636
Website: http://www.medifacts.com/
Email: info@medifacts.com
About Medifacts International
With offices in the US, Europe, and Asia, Medifacts International offers best-in-class science, technology, and service on a global basis in support of high-quality cardiac safety and efficacy data collection.Medifacts primary mission is to support the acquisition of data necessary to determine the safety and/or efficacy of drugs or devices involved in clinical trials. Medifacts has been instrumental in shaping the industry by setting standards of quality and unsurpassed service. Today, as cardiovascular experts with international reach, Medifacts continues to lead the industry by upholding a high standard of excellence.
With over 23 years of experience and offices Medifacts is a global leader in cardiac safety monitoring services. Medifacts' cardiac safety services include:
• ECG • Holter • Ambulatory Blood Pressure Monitoring (ABPM) • Home and Office Blood Pressure Monitoring • Other modalities (Spirometry, Echocardiography…) • Arterial compliance monitoring • Diagnostic telemonitoring
In support of these services, Medifacts offers:
• Global presence with offices on 3 continents • Project management • Site support (24x7x365) • Comprehensive, hands-on training of equipment and procedures offered on-site, at Investigator meetings, or via teleconference • Equipment provision • Full ‘gold standard’ ECG analysis
With unrivalled scientific leadership, Medifacts provides a full range of consultancy and analysis services throughout the development lifecycle and beyond. Consulting services include:
• Expert feedback in program and protocol design • Protocol writing • Interim summary reports • Biostatistics and expert reports • Final report writing
Medifacts has developed a pioneering technology infrastructure (the WebHeart® platform) which, coupled with scientific expertise and experienced and dedicated staff, has allowed Medifacts to emerge as one of the top service providers in the world.
WebHeart® is a proprietary, global, Web-based platform that offers a complete solution to acquiring, displaying, measuring, and managing Cardiac Safety data in clinical trials. This system allows for real-time access to ECG and Ambulatory Blood Pressure data. Because no actual programming is needed, the time and cost of both study setup and data submission are dramatically reduced. All ECG data can be converted into an XML format that meets FDA requirements and protocol setups are easily configured and expanded to accommodate additional information.
Medifacts International’s scientific expertise, proprietary WebHeart® technology, global presence and quality leadership are recognized throughout the industry as Medifacts is increasingly selected as the partner of choice by pharmaceutical and biotech drug developers.
18 articles about Medifacts International
-
RadPharm Merges with Medifacts International; Combined Company will be Called CoreLab Partners
2/11/2010
-
Medifacts International Drives Innovation in Telemedicine for Clinical Trials
12/16/2009
-
Medifacts International Inks $1.6 Million Diabetes Study with Top Five Pharmaceutical Company
11/24/2009
-
Medifacts International Reaches Milestone: 10,000 Sites under Management Worldwide
10/28/2009
-
Medifacts International Wins $2.7 Million Study with Top Ten Pharmaceutical Company
10/14/2009
-
Medifacts International Completes Spacelabs Healthcare Integration
10/8/2009
-
Medifacts International Buys Spacelabs Healthcare Unit
7/6/2009
-
Medifacts International Acquires Spacelabs Healthcare Clinical Trials Services Division
6/24/2009
-
SunTech Medical, Inc. Blood Pressure Monitor included in Medifacts International's Clinical Trial Services
4/27/2009
-
Medifacts International Forms Strategic Alliance with Suzuken for Cardiac Safety Services in Japan
4/23/2009
-
Strong Sales Growth and Industry Consolidation Increase Medifacts International's Global Ranking
11/28/2007
-
Medifacts International Inititates TQT Study in 10 Days
11/2/2007
-
Significant Signing Further Enhances Medifacts International's Position as One of the Top Cardiac Safety Services Providers
10/26/2007
-
Medifacts International Release: Record Turnaround Enables Significant Time and Cost Savings for Sponsor
10/12/2007
-
Medifacts International Uses WebHeart to Submit HL7 QT Datasets to FDA ECG Warehouse
5/30/2007
-
Medifacts International Divests CRO Division
4/4/2007
-
Medifacts International Announces Webinar: What Cardiac Safety Data Should Be Demonstrated For FDA Approval Of Non-Cardiac Drugs?
10/16/2006
-
Medifacts International Announces Executive Appointment
2/3/2006